MIRA INFORM
REPORT
|
Report Date : |
21.02.2011 |
Additional Information:
Anhui Biochem Pharmaceutical Co Ltd. has little business now, and Anhui Biochem United Pharmaceuticals Co., Ltd. mainly uses this name – Anhui Biochem Pharmaceutical Co ltd. as trade name to start its business.
IDENTIFICATION DETAILS
|
Correct Name : |
ANHUI BIOCHEM PHARMACEUTICAL CO., LTD. |
|
|
|
|
Registered Office : |
No. 108, Shahe Road, Taihe County, Fuyang,
Anhui Province, 236604 Pr |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
26.03.2003 |
|
|
|
|
Com. Reg. No.: |
341222000001734 |
|
|
|
|
Legal Form : |
Limited Liabilities Company |
|
|
|
|
Line of Business : |
Manufacturing & Selling Medicine |
RATING & COMMENTS
|
MIRA’s Rating : |
C |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
Status : |
Business Transferred |
|
Payment
Behaviour : |
--- |
|
Litigation : |
--- |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name & address
anhui biochem pharmaceutical CO., LTD.
no. 108,
236604 PR
108
TEL: 86 (0)
558-8629371/8635599 FAX: 86 (0)
558-8635599/2918597
Narrative report:
This refers to a
type of report whose format is different from that of a standard report. Such
type of report is provided when:
l
Information obtained is insufficient for compiling
a standard report.
l
The enquired co has been out of business or its
business address has been untraceable.
It should be noted that the time and manpower spent on preparing such
type of report might be greater than those on a standard report. On many
occasions, the information in this type of report still indicates the current
status of the enquired co. and serves as a useful reference to assess its
credit standing.
The provided telephone number is:
86 558-8629371
When we dialed the number, a gentleman Mr. Zhang answered.
He admitted the given English name and told us its Chinese name安徽贝克药业有限公司
He also released the following information:
SC was mainly engaged in manufacturing & selling medicine. At
present SC has transferred its business to Anhui Biochem United Pharmaceutical
Co., Ltd. so it has little business in recent years.
Mr. Zhang confirmed that SC has account in the given bank (Agricultural
Bank of
The address client given is:
No. 108,
According to Mr. Zhang, SC is operating in this address.
According
to the from the local Administration for Industry & Commerce (AIC-The
official body of issuing and renewing business license), SC’s registration
details are as below:
Incorporation Date :
March 26, 2003
Registration No. :
341222000001734
Registered Legal Form :
Limited Liabilities Co.
Duration : March 26, 2003 to March 25, 2018
SC’s registered business scope includes
manufacturing & selling chemical raw materials.
MAIN
SHAREHOLDERS:
Name % of
Shareholding
Wang
Zhibang 58.51
Liang
Yongming 24.12
Li
Fulin 8.60
Zheng
Gang 2.31
Wang
Zhihong 1.43
Ma
Yilu 1.25
Li
Yong 0.41
Zhang
Xiuling 0.38
Chen
Juan 0.30
Zhang
Na 0.30
The
other 17 individual shareholders 2.39
Mr. Zhang released that SC has transferred its business to Anhui Biochem
United Pharmaceutical Co., Ltd. so it has little
business in recent years.
===================================
Its products are mainly APIs, intermediates, fine chemicals, etc.
Website: http://www.bcpharm.com
SC has little business in recent years. In view of the
investigation results, caution is advised related to dealings with persons
claiming to represent such an entity
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.18 |
|
|
1 |
Rs.73.04 |
|
Euro |
1 |
Rs.61.43 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.